What You Should Know:
- Today Science 37 published a new report suggesting a momentous shift in the way that clinical trials are conducted.
- For the first time, more research sponsors and CROs are planning to run Agile/Hybrid Clinical Trials than ever before. Findings show that the vast majority or 77% of respondents plan to run an agile clinical trial in the next 12 months, compared to 59% for the previous 12 months.
Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37”), a
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Overcoming Key Hurdles in Decentralized Trials with Better Education
As with countless global industries, clinical trials were forced to move key functions online as COVID-19 swept the world in early 2020. Clinical research operations had to rapidly deploy remote approaches that were previously in the planning or pilot stages. While the uptake was rushed, the results have been largely positive. Decentralized clinical trials, and their near cousins that apply a hybrid approach of in-person and remote visits, are increasingly seen as a viable solution for biopharma
Read More
Decentralized Clinical Research Will Be A Paradigm-Shifting Trend
The field of clinical research is on the precipice of change, and for good reason. Traditional clinical trials and processes are primarily confined to sterile, isolated clinical settings that are often narrow in scope and provider-centric. Researchers of tomorrow, however, already are identifying accurate and effective new methods to conduct and draw meaning from their work, after concluding that current models for clinical research are not capturing participants’ real-world, lived experiences
Read More
Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment
What You Should Know:
- Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volasertib, a PLK-1 inhibitor in acute myeloid leukemia (AML) from Oncoheroes.
- Notable will leverage its high-fidelity Predictive Precision Medicines Platform to identify and select volasertib-responsive patients prior to their treatment and fast-track volasertib’s clinical development
Read More
Biotech Company Nuritas Raises $45M To Scale Its Peptide Discovery Platform
What You Should Know:
- Nuritas, a biotech company that uses proprietary AI to discover plant-based actives (peptides) and make the products we consume healthier and more sustainable raises $45M in Series B funding led by Cleveland Avenue, LLC. The round also included participation from Cultivian Sandbox Ventures, VisVires New Protein, U2’s Bono and The Edge, Salesforce CEO Marc Benioff and Ali Partovi.
- Founded in 2014, Nuritas’ computational approach to discovery uses
Read More
3 Barriers to Decentralized Clinical Trials Adoption
It’s official. Decentralized clinical trials have disrupted the clinical trial process for good. The COVID-19 pandemic elevated many digital innovations, proving that virtually connecting with patients is not only convenient but necessary when it comes to providing equitable access to cutting-edge treatments and clinical research.
Historically, traditional clinical trials have always experienced recruitment and retention challenges due to inconveniently located trial sites, lack of awareness
Read More
Decentralized Clinical Trials: Keys to Optimizing Diversity and Inclusion
The U.S. pharma industry and research intuitions have long struggled with increasing clinical trial diversity in an effective, sustainable, and scalable fashion. Clinical research, in general, acknowledges the universal struggle of recruiting enough participants from various demographic groups. For example, racial and ethnic minorities have been historically underrepresented in clinical trials—a problem that still persists today.
According to Deloitte, African Americans comprise 13% of the
Read More
Medable Secures $304M at $2.1B Valuation for Decentralized Clinical Trials Platform
What You Should Know:
- Decentralized Clinical Trials (DCT) leader Medable, today announced a $304M Series D funding round today – the company’s largest and fourth funding round in 18 months, bringing total capital raised to $521M – and valuation to $2B+. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire
Read More
Cerner Enviza Launches to Accelerate Therapies and Improve Patient Outcomes
What You Should Know:
- Today, Cerner announced the launch of Cerner Enviza, a new operating unit that offers solutions to help bring clarity to multi-dimensional data through real-world evidence and insights.
- Cerner Enviza℠ aims to accelerate the discovery, development and delivery of extraordinary insights and therapies to improve everyday health for all people globally. By combining decades of healthcare innovation, life sciences knowledge and collaborative research, Cerner
Read More
FDA Selects Aetion Evidence Platform to Assess In-Patient COVID-19 Treatments
What You Should Know:
- Aetion, a NYC-based leading real-world evidence (RWE) company, announced that the U.S. Food and Drug Administration (FDA) has contracted with them to use their Aetion Evidence Platform® to rapidly assess in-patient COVID-19 treatments and advance regulatory science to help determine when, where and how to use RWD.
- This project is designed to demonstrate how using a platform-based approach
Read More
